Risk of Second Cancer Lower With FOLFOX Than With FULFOL
Overall, adjuvant chemotherapy does not appear to increase the risk of second cancers for patients with stage III-IV colon cancer.
Diagnosis & Disease Information
Second Primary Cancers Less Likely With IMRT vs CRT for Prostate Tumors
Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
Data Support Shorter Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Disease-free survival and overall survival rates were similar with 3 months or 6 months of adjuvant chemotherapy.
Meat Intake After Diagnosis Not Tied to Colon Cancer Outcomes
There was no association between intake of unprocessed red meat or processed meat and the risk of colon cancer recurrence or mortality.
Stopping Adjuvant Treatment Early May Decrease DFS, OS in Stage III Colon Cancer
Early treatment discontinuation was associated with a decrease in survival, but early oxaliplatin discontinuation was not.
Artificial Intelligence Boosts Colonoscopy Cancer Detection
Computer-aided polyp detection could decrease variability in colonoscopy quality.
Very High Antibiotic Use May Up Risk for Proximal Colon Cancer
There was a positive association between more frequent antibiotic use and colorectal cancer overall.
Sex Inequalities Persist in Cancer Clinical Trials
Men nearly always outnumbered women, regardless of trial phase, cancer type, time period, or cancer incidence in the female population.
Higher Vitamin D Intake Linked to Reduced Risk of Early-Onset CRC
The association was stronger for dietary sources of vitamin D than supplemental vitamin D.
Celecoxib Provides No Survival Benefit for Patients With Stage III Colon Cancer
Celecoxib failed to reduce the risk of recurrence in patients with colon cancer.
- Loading...
Loading...
Next post in Gastrointestinal Cancers
Loading... 
Loading...